0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 141-160 of 497 Articles
Editor's Correspondence | 
Dimitri M. Drekonja, MD, MS
JAMA Intern Med. 2013;173(12):1153-1154. doi:10.1001/jamainternmed.2013.6251.

Editorial | 
Robert Steinbrook, MD; Rita F. Redberg, MD, MSc
JAMA Intern Med. 2013;173(12):1047-1048. doi:10.1001/jamainternmed.2013.6281.

Viewpoint | 
Susan Desmond-Hellmann, MD, MPH
JAMA Intern Med. 2013;173(12):1051-1052. doi:10.1001/jamainternmed.2013.826.

Special Article | 
Peter Doshi, PhD
JAMA Intern Med. 2013;173(11):1014-1016. doi:10.1001/jamainternmed.2013.490.
Includes: CME

Editor's Correspondence | 
Michael M. Madden, PhD; Frank M. Etzler, PhD; Thomas Gant, PhD
JAMA Intern Med. 2013;173(11):1034-1035. doi:10.1001/jamainternmed.2013.409.

Editor's Correspondence | 
Lee Cantrell, PharmD; Jeffrey Suchard, MD; Roy Gerona, PhD
JAMA Intern Med. 2013;173(11):1034-1035. doi:10.1001/jamainternmed.2013.832.

Editor's Correspondence | 
Bruno Charpiat, PharmD
JAMA Intern Med. 2013;173(11):1035-1036. doi:10.1001/jamainternmed.2013.418.

Editor's Correspondence | 
Li Zhou, MD, PhD; Saverio M. Maviglia, MD, MS; Roberto A. Rocha, MD, PhD
JAMA Intern Med. 2013;173(11):1035-1036. doi:10.1001/jamainternmed.2013.620.

Viewpoint | 
Iona Heath, MA, MB, BCh
JAMA Intern Med. 2013;173(11):956-957. doi:10.1001/jamainternmed.2013.970.

Editor's Correspondence | 
Shih-Wei Lai, MD; Kuan-Fu Liao, MD, MS
JAMA Intern Med. 2013;173(10):934-935. doi:10.1001/jamainternmed.2013.386.

Research Letters |  FREE
Gilles Safa, MD; Laure Darrieux, MD
JAMA Intern Med. 2013;173(10):924-926. doi:10.1001/jamainternmed.2013.374.

Research Letters |  FREE
Ziv Harel, MD, MSc; Shai Harel, MD, MS; Ron Wald, MDCM, MPH; et al.
JAMA Intern Med. 2013;173(10):929-930. doi:10.1001/jamainternmed.2013.379.
Includes: Supplemental Content

Invited Commentary | 
Eleni Linos, MD, DrPH
JAMA Intern Med. 2013;173(10):920-937. doi:10.1001/jamainternmed.2013.743.

Research Letters |  FREE
Sengwee Toh, ScD; Meghan A. Baker, MD, ScD; Jeffrey S. Brown, PhD; et al.
JAMA Intern Med. 2013;173(9):817-819. doi:10.1001/jamainternmed.2013.3004.
Includes: Supplemental Content

Original Investigation |  FREE
Sigrun A. Johannesdottir, BSc; Erzsébet Horváth-Puhó, MSc, PhD; Olaf M. Dekkers, MD, PhD, MSc, MA; et al.
JAMA Intern Med. 2013;173(9):743-752. doi:10.1001/jamainternmed.2013.122.
Includes: Supplemental Content

Research Letters |  FREE
Jeremy D. Keenan, MD, MPH; Paul M. Emerson, PhD; Bruce D. Gaynor, MD; et al.
JAMA Intern Med. 2013;173(9):821-823. doi:10.1001/jamainternmed.2013.3041.

Original Investigation |  FREE
Sejal Chowdhary, BS; Bolanle Bukoye, MPH, BS; Arjun M. Bhansali, MD; et al.
JAMA Intern Med. 2013;173(9):771-776. doi:10.1001/jamainternmed.2013.75.

Original Investigation |  FREE
Sarah D. Berry, MD, MPH; Yoojin Lee, MS, MPH; Shubing Cai, PhD; et al.
JAMA Intern Med. 2013;173(9):754-761. doi:10.1001/jamainternmed.2013.3795.

Invited Commentary | 
Eric Widera, MD
JAMA Intern Med. 2013;173(9):761-762. doi:10.1001/jamainternmed.2013.3801.

Original Investigation |  FREE
Qian Xiao, PhD; Rachel A. Murphy, PhD; Denise K. Houston, PhD; et al.
JAMA Intern Med. 2013;173(8):639-646. doi:10.1001/jamainternmed.2013.3283.
Includes: Supplemental Content

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA
Viewpoint  | 
Educational Opportunities With Postevent Debriefing
Paul C. Mullan, MD, MPH; David O. Kessler, MD, MSc; Adam Cheng, MD, FRCPC
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.